Optical Genome Mapping for the Diagnosis of Neurodevelopmental Disorders

Clinical trial NCT06347562 · UNKNOWN

Trial details

NCT number: NCT06347562
Sponsor: IRCCS Eugenio Medea
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Neurodevelopmental Disorder (Diagnosis)

Start date: 2022-06-15
Primary completion: 2025-06-14
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.